论文部分内容阅读
在接受重复性化疗的患者中,预期性恶心和呕吐的发生率为30%。为探讨患者的性别和受教育程度对化疗引发的预期性恶心和呕吐发生率的影响,Ruzsa A等对2008年5月1日至12月31日期间接受化疗的205例(男60例,女145例)乳腺癌和结直肠癌患者进行了问卷调查。化疗方案中均包含具有中度和高度催吐风险的药物。患者于化疗的第2和第3个周期接受调查。除了临床症状外,该调查还搜集了患者的年龄及其受教育程度信息。结果显示,总的预期性恶心和呕吐的发生率
In patients receiving repeat chemotherapy, the expected incidence of nausea and vomiting was 30%. To investigate the influence of patient’s gender and educational attainment on the incidence of chemotherapy-induced nausea and vomiting, Ruzsa A et al. Evaluated 205 patients who received chemotherapy from May 1 to December 31, 2008 (60 male and female 145 cases) breast cancer and colorectal cancer patients were surveyed. Chemotherapy regimens contain medications that are moderately and highly emetic. Patients were surveyed during the 2nd and 3rd cycles of chemotherapy. In addition to clinical symptoms, the survey also collected information about the patient’s age and education level. The results showed that the overall expected rate of nausea and vomiting